Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ishares Nasdaq Biotechnology (IBB)

Delayed Data
As of Aug 23
 +0.17 / +0.06%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

3 ETFs to Play Biotech's Bounce Back From Disaster
Aug 19 / TheStreet.com - Paid Partner Content


1 month+5.51% 3 years+15.44%
3 months+11.47% 5 years+26.65%
1 year-12.85% Since inception+7.38%
Data through 08/24/2016

Quote Details

Previous close$296.01
Open day’s range295.45 – 298.07
Net asset value (NAV)296.23 (08/23/2016)
Daily volume926,847
Average volume (3 months)1,616,510
Data as of 08/23/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+26.65%+15.32%
Expense Gross exp ratio0.47%0.47%
Risk 5 year sharpe ratio1.041.12
Net assets$7.4B$1.2B
Average market cap$13.9B$31.2B
Average P/E20.018.7
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen8.47%
CELG Celgene8.27%
BIIB Biogen7.78%
REGN Regeneron Pharmaceuticals7.48%
GILD Gilead Sciences7.10%
ILMN Illumina Inc4.34%
MYL Mylan NV4.20%
VRTX Vertex Pharmaceuticals Inc4.05%
ALXN Alexion Pharmaceuticals Inc3.31%
INCY Incyte Corp3.00%

Partner Offers

Search for Jobs